Evidence map›Paper›PMID 39430754›Full record

ArticleFrontiers in immunology2024

Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing.

Shengyi Zhang, Xinyi Zhang, Zhikai Xiahou, Shunqing Zuo, Jialong Xue, Yi Zhang

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Mast cell driven immunometabolism as a therapeutic entry point in ESCC.Frontiers in cell and developmental biology · 2026
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Shengyi Zhang *Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xinyi Zhang *Clinical Medical College, Southwest Medical University, Luzhou, China.
Zhikai Xiahou *China Institute of Sport and Health Science, Beijing Sport University, Beijing, China.
Shunqing ZuoSongjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jialong XueSongjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yi ZhangSongjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal cancer (EC) is a major health issue, ranking seventh in incidence and sixth in mortality worldwide. Despite advancements in multidisciplinary treatment approaches, the 5-year survival rate for EC remains low at 21%. Challenges in EC treatment arise from late-stage diagnosis, high malignancy, and poor prognosis. Understanding the tumor microenvironment is critical, as it includes various cellular and extracellular components that influence tumor behavior and treatment response. Mast cells (MCs), as tissue-resident immune cells, play dual roles in tumor dynamics. High-throughput single-cell RNA sequencing offers a powerful tool for analyzing tumor heterogeneity and immune interactions, although its application in EC is limited. Methods: In this study, we investigated the immune microenvironment of EC using single-cell RNA sequencing and established a comprehensive immune profile. We also performed analysis of upstream transcription factors and downstream pathway enrichment to further comprehensively decipher MCs in EC. Besides, we performed knockdown experiments to explore the role of epidermal growth factor receptor ( Results: Our analysis identified 11 major cell types, of which MCs were particularly present in pericarcinoma tissues. Further grouping of the 5,001 MCs identified 8 distinct subtypes, including Conclusion: These findings illuminate the complex interactions within the tumor microenvironment of EC and suggest that targeting specific MCs subtypes, particularly via the

Indexed as

Esophageal NeoplasmsMast CellsSingle-Cell AnalysisTumor MicroenvironmentBiomarkers, TumorCell Line, TumorErbB ReceptorsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMalePrognosisRNA-SeqSequence Analysis, RNASignal TransductionBiomarkers, TumorEGFR protein, humanErbB ReceptorsEGFR signaling pathwayesophageal cancermast cellsprognostic modelsingle-cell RNA sequencing

Identifiers

PMID39430754
PMCPMC11486721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.